Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Gender differences affect allergy prevalence, severity, and response to environmental toxins, with women often more affected than men.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

SHA lowers the hairline quickly and patients are usually happy with the results if they are good candidates.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

The procedure effectively created natural-looking hairlines and improved facial balance in female patients.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Nonandrogenic factors like oxidative stress and microinflammation are important in hair loss progression.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

The 11th AICPE Congress in Rimini was a major event in European aesthetic plastic surgery.

Finasteride may lower cholesterol and slow heart disease progression.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Human hair follicle cells can grow hair when put into mouse skin if they stay in contact with mouse cells.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Improving the environment and cell interactions is key for creating human hair in the lab.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

The document concludes that while "hair follicle cloning" shows promise for unlimited donor hair, it faces challenges with consistency and safety in humans.

Transplanted transected hair follicles can survive but grow at unsatisfactory rates and are thinner, suggesting limited potential for unlimited donor hair supply.

Cutting hair follicles into pieces for transplantation results in poor growth and thinner hair, and the technique is more invasive than previously thought.

Growing human skin cells in a 3D environment can stimulate new hair growth.